AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALB
  4. [Form 4] Albemarle Corporation Insider Trading Activity

[Form 4] Albemarle Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Krupa Ander C., identified as an officer (General Counsel & Secretary), reported an insider acquisition in Albemarle Corp (ALB) on 08/06/2025. The Form 4 shows an award of 7,430 restricted stock units (RSUs) granted at a $0 price and reported under transaction code A (acquisition).

The RSUs are described to vest 100% on August 6, 2028 per the award agreement. Following the reported grant the filing shows 11,771 shares beneficially owned by the reporting person. The form is signed by an attorney-in-fact on 08/08/2025.

Krupa Ander C., indicata come dirigente (General Counsel & Secretary), ha segnalato un'acquisizione insider in Albemarle Corp (ALB) il 08/06/2025. Il Modulo 4 riporta l'assegnazione di 7,430 restricted stock units (RSU) con prezzo di attribuzione $0, segnalata con il codice di transazione A (acquisizione).

Le RSU maturano 100% il 6 agosto 2028 secondo l'accordo di assegnazione. Dopo la concessione comunicata, il documento indica che la persona dichiarante possiede beneficiariamente 11,771 azioni. Il modulo 猫 stato firmato da un procuratore il 08/08/2025.

Krupa Ander C., indicada como ejecutiva (General Counsel & Secretary), inform贸 una adquisici贸n de insider en Albemarle Corp (ALB) el 08/06/2025. El Formulario 4 muestra una adjudicaci贸n de 7,430 unidades de acciones restringidas (RSU) otorgadas a precio de $0 y registradas con el c贸digo de transacci贸n A (补诲辩耻颈蝉颈肠颈贸苍).

Las RSU est谩n sujetas a vencimiento por el 100% el 6 de agosto de 2028 seg煤n el acuerdo de concesi贸n. Tras la adjudicaci贸n notificada, la presentaci贸n indica que la persona informante posee beneficiariamente 11,771 acciones. El formulario est谩 firmado por un apoderado el 08/08/2025.

Krupa Ander C.電� 鞛勳洂(General Counsel & Secretary)鞙茧 響滌嫓霅橃柎 鞛堨溂氅�, 08/06/2025鞐� Albemarle Corp (ALB) 甏�霠� 雮措秬鞛� 旆摑鞚� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 瓯半灅 旖旊摐 A(旆摑)搿� 氤搓碃霅� 臧�瓴� $0鞐愳劀 攵�鞐悳 7,430臧滌潣 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 靾橃棳臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟.

頃措嫻 RSU電� 靾橃棳 瓿勳暯鞐� 霐半澕 2028雲� 8鞗� 6鞚检棎 100% 氩犾姢韺�霅橂姅 瓴冹溂搿� 靹る獏霅橃柎 鞛堨姷雼堧嫟. 氤搓碃霅� 靾橃棳 鞚错泟, 鞝滌稖靹滊鞐愲姅 氤搓碃鞚胳澊 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕 靾橁皜 11,771欤�搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 鞏戩嫕鞚� 雽�毽澑鞚� 08/08/2025鞐� 靹滊獏頄堨姷雼堧嫟.

Krupa Ander C., indiqu茅e comme dirigeante (General Counsel & Secretary), a d茅clar茅 une acquisition d'initi茅 chez Albemarle Corp (ALB) le 08/06/2025. Le formulaire 4 montre l'attribution de 7,430 unit茅s d'actions restreintes (RSU) accord茅es 脿 un prix de $0 et rapport茅es sous le code de transaction A (acquisition).

Les RSU sont d茅crites comme se vestant 脿 100 % le 6 ao没t 2028 selon l'accord d'attribution. Apr猫s l'octroi d茅clar茅, le dossier indique que la personne d茅clarante poss猫de 脿 titre b茅n茅ficiaire 11,771 actions. Le formulaire est sign茅 par un mandataire le 08/08/2025.

Krupa Ander C., ausgewiesen als leitende Angestellte (General Counsel & Secretary), meldete am 08/06/2025 einen Insider-Zukauf in Albemarle Corp (ALB). Im Formular 4 ist eine Zuteilung von 7,430 Restricted Stock Units (RSUs) zu einem Ausgabepreis von $0 aufgef眉hrt und unter dem Transaktionscode A (Erwerb) gemeldet.

Den RSUs zufolge erfolgen die Vesting-Bedingungen so, dass 100% am 6. August 2028 gem盲脽 dem Zuteilungsvertrag f盲llig werden. Nach der gemeldeten Gew盲hrung zeigt die Meldung, dass die meldende Person wirtschaftlich beg眉nstigt 11,771 Aktien besitzt. Das Formular wurde am 08/08/2025 von einem Bevollm盲chtigten unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine executive compensation grant of 7,430 RSUs to Albemarle's General Counsel, vesting in three years; not immediately market-moving.

The filing documents a non鈥慶ash award: 7,430 RSUs granted on 08/06/2025 at a reported price of $0, increasing beneficial ownership to 11,771 shares. Such awards are typical for aligning management incentives and are ordinarily part of annual or hire-related compensation programs. The grant vests fully on 08/06/2028, so there is no immediate share issuance or sale pressure. On its face this disclosure appears procedural and unlikely to have material near-term impact on Albemarle's valuation.

TL;DR: Compensation disclosure appears standard; vesting schedule and documentation are specified, supporting alignment with long-term performance.

The Form 4 identifies the recipient as an officer (General Counsel & Secretary) and specifies RSUs that vest 100% on August 6, 2028. The award's full vesting date and the $0 grant price are explicitly disclosed, meeting transparency norms under Section 16. From a governance perspective, the timetable ties pay to tenure or performance over three years. The filing was executed by an attorney-in-fact, which is common for administrative filings.

Krupa Ander C., indicata come dirigente (General Counsel & Secretary), ha segnalato un'acquisizione insider in Albemarle Corp (ALB) il 08/06/2025. Il Modulo 4 riporta l'assegnazione di 7,430 restricted stock units (RSU) con prezzo di attribuzione $0, segnalata con il codice di transazione A (acquisizione).

Le RSU maturano 100% il 6 agosto 2028 secondo l'accordo di assegnazione. Dopo la concessione comunicata, il documento indica che la persona dichiarante possiede beneficiariamente 11,771 azioni. Il modulo 猫 stato firmato da un procuratore il 08/08/2025.

Krupa Ander C., indicada como ejecutiva (General Counsel & Secretary), inform贸 una adquisici贸n de insider en Albemarle Corp (ALB) el 08/06/2025. El Formulario 4 muestra una adjudicaci贸n de 7,430 unidades de acciones restringidas (RSU) otorgadas a precio de $0 y registradas con el c贸digo de transacci贸n A (补诲辩耻颈蝉颈肠颈贸苍).

Las RSU est谩n sujetas a vencimiento por el 100% el 6 de agosto de 2028 seg煤n el acuerdo de concesi贸n. Tras la adjudicaci贸n notificada, la presentaci贸n indica que la persona informante posee beneficiariamente 11,771 acciones. El formulario est谩 firmado por un apoderado el 08/08/2025.

Krupa Ander C.電� 鞛勳洂(General Counsel & Secretary)鞙茧 響滌嫓霅橃柎 鞛堨溂氅�, 08/06/2025鞐� Albemarle Corp (ALB) 甏�霠� 雮措秬鞛� 旆摑鞚� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 瓯半灅 旖旊摐 A(旆摑)搿� 氤搓碃霅� 臧�瓴� $0鞐愳劀 攵�鞐悳 7,430臧滌潣 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 靾橃棳臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟.

頃措嫻 RSU電� 靾橃棳 瓿勳暯鞐� 霐半澕 2028雲� 8鞗� 6鞚检棎 100% 氩犾姢韺�霅橂姅 瓴冹溂搿� 靹る獏霅橃柎 鞛堨姷雼堧嫟. 氤搓碃霅� 靾橃棳 鞚错泟, 鞝滌稖靹滊鞐愲姅 氤搓碃鞚胳澊 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕 靾橁皜 11,771欤�搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 鞏戩嫕鞚� 雽�毽澑鞚� 08/08/2025鞐� 靹滊獏頄堨姷雼堧嫟.

Krupa Ander C., indiqu茅e comme dirigeante (General Counsel & Secretary), a d茅clar茅 une acquisition d'initi茅 chez Albemarle Corp (ALB) le 08/06/2025. Le formulaire 4 montre l'attribution de 7,430 unit茅s d'actions restreintes (RSU) accord茅es 脿 un prix de $0 et rapport茅es sous le code de transaction A (acquisition).

Les RSU sont d茅crites comme se vestant 脿 100 % le 6 ao没t 2028 selon l'accord d'attribution. Apr猫s l'octroi d茅clar茅, le dossier indique que la personne d茅clarante poss猫de 脿 titre b茅n茅ficiaire 11,771 actions. Le formulaire est sign茅 par un mandataire le 08/08/2025.

Krupa Ander C., ausgewiesen als leitende Angestellte (General Counsel & Secretary), meldete am 08/06/2025 einen Insider-Zukauf in Albemarle Corp (ALB). Im Formular 4 ist eine Zuteilung von 7,430 Restricted Stock Units (RSUs) zu einem Ausgabepreis von $0 aufgef眉hrt und unter dem Transaktionscode A (Erwerb) gemeldet.

Den RSUs zufolge erfolgen die Vesting-Bedingungen so, dass 100% am 6. August 2028 gem盲脽 dem Zuteilungsvertrag f盲llig werden. Nach der gemeldeten Gew盲hrung zeigt die Meldung, dass die meldende Person wirtschaftlich beg眉nstigt 11,771 Aktien besitzt. Das Formular wurde am 08/08/2025 von einem Bevollm盲chtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krupa Ander C.
(Last) (First) (Middle)
4250 CONGRESS STREET
SUITE 900
(Street)
CHARLOTTE NC 28209
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel & Sec
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/06/2025 A 7,430(1) A $0 11,771 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted Stock Units that vest 100% on August 6, 2028, subject to the terms of the award agreement.
Remarks:
/s/ Rebekah Richards, Attorney-in-Fact 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What insider transaction did Albemarle (ALB) report on Form 4?

The Form 4 reports a grant of 7,430 restricted stock units (RSUs) to Krupa Ander C. on 08/06/2025, reported as an acquisition (code A).

Who is the reporting person and what is their role at ALB?

The reporting person is Krupa Ander C., listed as an officer with the title General Counsel & Secretary.

When do the RSUs vest and are there conditions disclosed?

The RSUs vest 100% on August 6, 2028, as stated in the explanation; no additional conditions are specified in this filing.

How many Albemarle shares does the reporting person beneficially own after the transaction?

The filing shows 11,771 shares beneficially owned following the reported transaction.

Was there any cash paid for the award and who signed the form?

The grant is reported at a $0 price. The Form 4 was signed by Rebekah Richards, Attorney-in-Fact on 08/08/2025.
Stock ALB logo
Albemarle Corp

NYSE:ALB

ALB Rankings

#1477 Ranked by Market Cap
#1421 Ranked by Dividends

ALB Latest News

Aug 11, 2025
Albemarle Announces Enhanced Organizational Structure
Jul 30, 2025
Albemarle Announces New General Counsel, Corporate Secretary and Chief Compliance Officer
Jul 30, 2025
Albemarle Reports Second Quarter 2025 Results
Jul 22, 2025
Albemarle Announces Quarterly Common Stock Dividend
Jun 18, 2025
Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

ALB Latest SEC Filings

Aug 8, 2025
[Form 3] Albemarle Corporation Initial Statement of Beneficial Ownership
Aug 5, 2025
[SCHEDULE 13G/A] Albemarle Corporation SEC Filing
Aug 4, 2025
[8-K] Albemarle Corporation Reports Material Event
Aug 4, 2025
[10-Q] Albemarle Corporation Quarterly Earnings Report
Jul 30, 2025
[8-K] Albemarle Corporation Reports Material Event

ALB Stock Data

7.92B
117.18M
0.39%
98.76%
12.52%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
United States
CHARLOTTE